
Cirqle Biomedical
Develops a next generation contraceptive product.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | $1.0m | Debt | |
Total Funding | 000k |
EUR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
OUI is an innovative company specializing in hormone-free contraception through a unique vaginal capsule. This capsule dissolves rapidly upon insertion, releasing a formulation that temporarily reinforces cervical mucus, making it impenetrable to sperm. This method ensures effective birth control within a minute without the use of hormones, minimizing side effects. OUI targets women seeking a convenient, elegant, and easy-to-use contraceptive solution. The company operates in the women's health market, focusing on non-hormonal birth control methods. OUI's business model revolves around the sale of its proprietary vaginal capsules, generating revenue through direct sales and partnerships with healthcare providers. The company aims to transform scientific discoveries into practical products that significantly impact women's health.
Keywords: hormone-free, vaginal capsule, birth control, cervical mucus, non-hormonal, women's health, contraception, rapid action, minimal side effects, innovative.